Price (delayed)
$18.485
Market cap
$1.42B
P/E Ratio
9.83
Dividend/share
N/A
EPS
$1.88
Enterprise value
$1.26B
inmode offers the most exciting and effective aesthetic solutions with fractora, forma/plus, lumeccca, diolaze and bodyfx. fractora: bipolar radio-frequency fractional treatment for superior improvements in texture, wrinkles, acne scars and
There are no recent dividends present for INMD.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.